Estorra eszopiclone: Phase III data; under FDA review

In a 2-week double-blind Phase III trial in 231 elderly patients, Estorra significantly improved sleep onset, sleep

Read the full 174 word article

How to gain access

Continue reading with a
two-week free trial.